Cytosorbents Crecimiento futuro
Future controles de criterios 2/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Cytosorbents de 53.8% y 22.3% respectivamente, mientras que el BPA crecerá en un 55.4% al año.
Información clave
53.8%
Tasa de crecimiento de los beneficios
55.4%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Medical Equipment | 17.1% |
Tasa de crecimiento de los ingresos | 22.3% |
Rentabilidad financiera futura | n/a |
Cobertura de analistas | Low |
Última actualización | 14 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
The Market Lifts Cytosorbents Corporation (NASDAQ:CTSO) Shares 43% But It Can Do More
Oct 01Investors Continue Waiting On Sidelines For Cytosorbents Corporation (NASDAQ:CTSO)
Jul 04Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?
Mar 16Take Care Before Jumping Onto Cytosorbents Corporation (NASDAQ:CTSO) Even Though It's 28% Cheaper
Jan 06Is Cytosorbents (NASDAQ:CTSO) Using Too Much Debt?
Nov 10Shareholders Should Be Pleased With Cytosorbents Corporation's (NASDAQ:CTSO) Price
Jul 13Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?
May 16We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate
Mar 08CytoSorbents secures $4.3M contract by U.S. Department of Defense
Oct 06CytoSorbents stock rises on US DoD contract to develop device for universal plasma
Sep 09We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate
Sep 02CytoSorbents gets reimbursement for CytoSorb in Turkey
Aug 23CytoSorbents stock rises 10% as Israel approves coverage for CytoSorb system
Aug 17Cytosorbents GAAP EPS of -$0.25 misses by $0.13, revenue of $8.5M misses by $1.06M
Aug 02Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 53 | -6 | -12 | -11 | 3 |
12/31/2025 | 43 | -13 | -21 | -20 | 3 |
12/31/2024 | 39 | -17 | -26 | -26 | 3 |
9/30/2024 | 38 | -19 | -19 | -18 | N/A |
6/30/2024 | 37 | -26 | -22 | -21 | N/A |
3/31/2024 | 37 | -28 | -24 | -23 | N/A |
12/31/2023 | 36 | -29 | -23 | -22 | N/A |
9/30/2023 | 37 | -23 | -22 | -21 | N/A |
6/30/2023 | 36 | -26 | -24 | -22 | N/A |
3/31/2023 | 35 | -31 | -30 | -23 | N/A |
12/31/2022 | 35 | -33 | -35 | -28 | N/A |
9/30/2022 | 36 | -41 | -36 | -28 | N/A |
6/30/2022 | 38 | -36 | -34 | -26 | N/A |
3/31/2022 | 41 | -29 | -24 | -20 | N/A |
12/31/2021 | 43 | -25 | -18 | -14 | N/A |
9/30/2021 | 44 | -16 | -12 | -10 | N/A |
6/30/2021 | 45 | -10 | -11 | -9 | N/A |
3/31/2021 | 43 | -9 | -7 | -5 | N/A |
12/31/2020 | 41 | -8 | -7 | -6 | N/A |
9/30/2020 | 36 | -11 | -10 | -9 | N/A |
6/30/2020 | 32 | -17 | -12 | -11 | N/A |
3/31/2020 | 28 | -18 | -17 | -16 | N/A |
12/31/2019 | 25 | -19 | -18 | -17 | N/A |
9/30/2019 | 24 | -21 | -17 | -15 | N/A |
6/30/2019 | 23 | -17 | -14 | -13 | N/A |
3/31/2019 | 23 | -19 | -14 | -13 | N/A |
12/31/2018 | 23 | -17 | -12 | -11 | N/A |
9/30/2018 | 21 | -15 | -10 | -9 | N/A |
6/30/2018 | 19 | -14 | N/A | -8 | N/A |
3/31/2018 | 17 | -10 | N/A | -7 | N/A |
12/31/2017 | 15 | -9 | N/A | -6 | N/A |
9/30/2017 | 14 | -11 | N/A | -7 | N/A |
6/30/2017 | 12 | -10 | N/A | -7 | N/A |
3/31/2017 | 11 | -11 | N/A | -7 | N/A |
12/31/2016 | 10 | -12 | N/A | -7 | N/A |
9/30/2016 | 8 | -9 | N/A | -8 | N/A |
6/30/2016 | 7 | -10 | N/A | -8 | N/A |
3/31/2016 | 6 | -5 | N/A | -8 | N/A |
12/31/2015 | 5 | -9 | N/A | -9 | N/A |
9/30/2015 | 4 | -17 | N/A | -9 | N/A |
6/30/2015 | 4 | -17 | N/A | -9 | N/A |
3/31/2015 | 4 | -21 | N/A | -8 | N/A |
12/31/2014 | 4 | -19 | N/A | -6 | N/A |
9/30/2014 | 4 | -9 | N/A | -5 | N/A |
6/30/2014 | 4 | -8 | N/A | -4 | N/A |
3/31/2014 | 3 | -7 | N/A | -3 | N/A |
12/31/2013 | 2 | -7 | N/A | -3 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Se prevé que CTSO siga sin ser rentable en los próximos 3 años.
Beneficios vs. Mercado: Se prevé que CTSO siga sin ser rentable en los próximos 3 años.
Beneficios de alto crecimiento: Se prevé que CTSO siga sin ser rentable en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (22.3% al año) de CTSO crezcan más rápidamente que los del mercado US (8.9% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos (22.3% al año) de CTSO crezcan más rápidamente que un 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de CTSO se prevé que sea elevada dentro de 3 años.